Krishna Institute of Medical Sciences has allotted 77,02,182 convertible warrants on a preferential basis to Dr. Abhinay Bollineni (Promoter), Adwik Bollineni (Promoter) and Bharas Ventures LLP (a Promoter Group entity) on receipt of 25% of the issue price of the warrants i.e. Rs 149.99 crore.
The warrants shall be convertible into equity shares of the Company within a period of 18 (Eighteen) months from the date of allotment of the warrants.